Maryland Capital Management’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $13.1M | Buy |
80,314
+3,157
| +4% | +$534K | 1.09% | 29 |
|
|
2022
Q2 | $13.7M | Sell |
77,157
-405
| -0.5% | -$72.2K | 1.08% | 33 |
|
|
2022
Q1 | $13.7M | Buy |
77,562
+4,667
| +6% | +$794K | 0.86% | 35 |
|
|
2021
Q4 | $12.5M | Buy |
72,895
+6,930
| +11% | +$1.13M | 0.67% | 34 |
|
|
2021
Q3 | $10.7M | Sell |
65,965
-2,835
| -4% | -$484K | 0.64% | 39 |
|
|
2021
Q2 | $11.3M | Buy |
68,800
+2,922
| +4% | +$484K | 0.68% | 36 |
|
|
2021
Q1 | $10.8M | Buy |
65,878
+6,250
| +10% | +$1.01M | 0.72% | 35 |
|
|
2020
Q4 | $9.38M | Buy |
59,628
+5,419
| +10% | +$800K | 0.66% | 36 |
|
|
2020
Q3 | $8.07M | Sell |
54,209
-1,871
| -3% | -$277K | 0.66% | 38 |
|
|
2020
Q2 | $7.89M | Buy |
56,080
+1,595
| +3% | +$232K | 0.73% | 36 |
|
|
2020
Q1 | $7.14M | Buy |
54,485
+10,125
| +23% | +$1.44M | 0.85% | 33 |
|
|
2019
Q4 | $6.47M | Buy |
44,360
+3,184
| +8% | +$432K | 0.69% | 41 |
|
|
2019
Q3 | $5.33M | Buy |
41,176
+2,400
| +6% | +$316K | 0.61% | 43 |
|
|
2019
Q2 | $5.4M | Buy |
38,776
+3,774
| +11% | +$522K | 0.64% | 44 |
|
|
2019
Q1 | $4.89M | Buy |
35,002
+3,642
| +12% | +$488K | 0.61% | 45 |
|
|
2018
Q4 | $4.05M | Buy |
31,360
+2,388
| +8% | +$333K | 0.58% | 46 |
|
|
2018
Q3 | $4M | Buy |
28,972
+649
| +2% | +$86.2K | 0.52% | 45 |
|
|
2018
Q2 | $3.44M | Buy |
28,323
+1,864
| +7% | +$233K | 0.48% | 50 |
|
|
2018
Q1 | $3.39M | Buy |
26,459
+979
| +4% | +$132K | 0.49% | 47 |
|
|
2017
Q4 | $3.56M | Sell |
25,480
-3,265
| -11% | -$455K | 0.53% | 46 |
|
|
2017
Q3 | $3.74M | Buy |
28,745
+468
| +2% | +$62K | 0.58% | 45 |
|
|
2017
Q2 | $3.74M | Buy |
28,277
+320
| +1% | +$40.8K | 0.54% | 46 |
|
|
2017
Q1 | $3.48M | Sell |
27,957
-1,730
| -6% | -$207K | 0.52% | 47 |
|
|
2016
Q4 | $3.42M | Buy |
29,687
+2,347
| +9% | +$271K | 0.53% | 47 |
|
|
2016
Q3 | $3.23M | Buy |
27,340
+2,418
| +10% | +$293K | 0.48% | 46 |
|
|
2016
Q2 | $3.02M | Sell |
24,922
-853
| -3% | -$96.9K | 0.48% | 46 |
|
|
2016
Q1 | $2.79M | Sell |
25,775
-601
| -2% | -$62.2K | 0.4% | 45 |
|
|
2015
Q4 | $2.71M | Buy |
26,376
+1,601
| +6% | +$161K | 0.4% | 46 |
|
|
2015
Q3 | $2.31M | Sell |
24,775
-1,282
| -5% | -$124K | 0.39% | 48 |
|
|
2015
Q2 | $2.54M | Buy |
26,057
+48
| +0.2% | +$4.81K | 0.4% | 48 |
|
|
2015
Q1 | $2.62M | Sell |
26,009
-1,974
| -7% | -$201K | 0.41% | 49 |
|
|
2014
Q4 | $2.93M | Buy |
27,983
+2,866
| +11% | +$302K | 0.48% | 43 |
|
|
2014
Q3 | $2.68M | Buy |
25,117
+838
| +3% | +$86.9K | 0.46% | 46 |
|
|
2014
Q2 | $2.54M | Sell |
24,279
-795
| -3% | -$80.4K | 0.45% | 48 |
|
|
2014
Q1 | $2.46M | Sell |
25,074
-5,636
| -18% | -$523K | 0.45% | 46 |
|
|
2013
Q4 | $2.81M | Sell |
30,710
-7,606
| -20% | -$701K | 0.45% | 47 |
|
|
2013
Q3 | $3.32M | Buy |
38,316
+1,178
| +3% | +$106K | 0.54% | 44 |
|
|
2013
Q2 | $3.19M | Buy |
+37,138
| New | +$3.15M | 0.55% | 44 |
|
Other funds holding JNJ
Maryland Capital Management's JNJ Position: Q3 2022 in Review
Maryland Capital Management increased its Johnson & Johnson (JNJ) stake by 4.1% in Q3 2022, buying an estimated $534K and bringing the position to 80,314 shares worth $13.1M. The position accounts for 1.09% of the portfolio, ranked #29.
Maryland Capital Management first reported a position in JNJ in Q2 2013 and has held it in 38 quarters since. The position peaked at $13.7M in Q1 2022. 3,622 funds tracked by Wall St. Rank hold JNJ as of Q3 2022.
- Maryland Capital Management held 80,314 shares of Johnson & Johnson worth $13.1M as of Q3 2022.
- Maryland Capital Management bought 3,157 Johnson & Johnson shares in Q3 2022, an estimated $534K.
- Johnson & Johnson made up 1.09% of Maryland Capital Management's portfolio in Q3 2022, its #29 holding.
- Maryland Capital Management first reported a position in Johnson & Johnson in Q2 2013 and has held it in 38 quarters since.
- Maryland Capital Management's Johnson & Johnson position peaked at $13.7M in Q1 2022.
- 3,622 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2022.
Based on Maryland Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.